Glutamate, Dopamine, and Schizophrenia: From Pathophysiology to Treatment

Implications of Normal Brain Development for the Pathogenesis of Schizophrenia

Weinberger, D. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190080012 · Cited by 3,724 · see citing works

Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans: Psychotomimetic, Perceptual, Cognitive, and Neuroendocrine Responses

Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330 · see citing works

Recent advances in the phencyclidine model of schizophrenia

(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904 · see citing works

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220 · see citing works

Effect of Chlorpromazine or Haloperidol on Formation of 3‐Methoxytyramine and Normetanephrine in Mouse Brain

Carlsson, A., & Lindqvist, M. (1963) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1963.tb01730.x · Cited by 2,156 · see citing works

Dopamine in schizophrenia: a review and reconceptualization

Davis, K. L., Kahn, R. S., Ko, G., & Davidson, M. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.11.1474 · Cited by 2,021 · see citing works

Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex

Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793 · see citing works

Glutamate receptor dysfunction and schizophrenia

Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685 · see citing works

The neuropathology of schizophrenia

Harrison, P. J. (1999) · Brain · doi:10.1093/brain/122.4.593 · Cited by 1,677 · see citing works

The Neuropsychopharmacology of Phencyclidine: From NMDA Receptor Hypofunction to the Dopamine Hypothesis of Schizophrenia

Jentsch, J., & Roth, R. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00060-8 · Cited by 1,349 · see citing works

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

Laruelle, M., Abi-Dargham, A., van Dyck, C. H., Gil, R., D'Souza, C. D., Erdos, J., McCance, E., Rosenblatt, W., Fingado, C., Zoghbi, S. S., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9235 · Cited by 1,291 · see citing works

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method

Breier, A., Su, T.-P., Saunders, R., Carson, R. E., Kolachana, B. S., de Bartolomeis, A., Weinberger, D. R., Weisenfeld, N., Malhotra, A. K., Eckelman, W. C., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2569 · Cited by 1,154 · see citing works

The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones

Smith, A. D., & Bolam, J. P. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90106-k · Cited by 1,040 · see citing works

Increased baseline occupancy of D ₂ receptors by dopamine in schizophrenia

Abi-Dargham, A., Rodenhiser, J., Printz, D., Zea-Ponce, Y., Gil, R., Kegeles, L. S., Weiss, R., Cooper, T. B., Mann, J. J., Van Heertum, R. L., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.14.8104 · Cited by 1,020 · see citing works

Reversal of Phencyclidine Effects by a Group II Metabotropic Glutamate Receptor Agonist in Rats

Moghaddam, B., & Adams, B. W. (1998) · Science · doi:10.1126/science.281.5381.1349 · Cited by 1,006 · see citing works

Imaging Synaptic Neurotransmission with <i>in Vivo</i> Binding Competition Techniques: A Critical Review

Laruelle, M. (2000) · Journal of Cerebral Blood Flow &amp; Metabolism · doi:10.1097/00004647-200003000-00001 · Cited by 944 · see citing works

Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens

Nicola, S. M., Surmeier, D. J., & Malenka, R. C. (2000) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.23.1.185 · Cited by 931 · see citing works

Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia

Lahti, A. C., Koffel, B., LaPorte, D. J., & Tamminga, C. A. (1995) · Neuropsychopharmacology · doi:10.1016/0893-133x(94)00131-i · Cited by 921 · see citing works

The Emerging Role of Glutamate in the Pathophysiology and Treatment of Schizophrenia

GOFF, D. C., & Coyle, J. T. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.9.1367 · Cited by 914 · see citing works

Projections from the Rat Prefrontal Cortex to the Ventral Tegmental Area: Target Specificity in the Synaptic Associations with Mesoaccumbens and Mesocortical Neurons

Carr, D. B., & Sesack, S. R. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-10-03864.2000 · Cited by 880 · see citing works

Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine Neurons

Seeman, P., & Lee, T. (1975) · Science · doi:10.1126/science.1145194 · Cited by 869 · see citing works

Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort.

Abi-Dargham, A., Gil, R. B., Krystal, J., Baldwin, R., Seibyl, J., Bowers, M., van Dyck, C., Charney, D., Innis, R., & Laruelle, M. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.6.761 · Cited by 860 · see citing works

D1 receptors in prefrontal cells and circuits

Goldman-Rakic, P. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00045-4 · Cited by 807 · see citing works

The origins of two-state spontaneous membrane potential fluctuations of neostriatal spiny neurons

Wilson, C. J., & Kawaguchi, Y. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-07-02397.1996 · Cited by 798 · see citing works

Increased dopamine transmission in schizophrenia: relationship to illness phases.

Laruelle, M., Abi-Dargham, A., Gil, R. B., Kegeles, L., & Innis, R. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00067-0 · Cited by 744 · see citing works

Prefrontal Dopamine D₁Receptors and Working Memory in Schizophrenia

Abi-Dargham, A., Mawlawi, O., Lombardo, I., Gil, R., Martinez, D., Huang, Y., Hwang, D.-R., Keilp, J., Kochan, L., Van Heertum, R., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03708.2002 · Cited by 724 · see citing works

Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET

Okubo, Y., Suhara, T., Suzuki, K., Kobayashi, K., Inoue, O., Terasaki, O., Someya, Y., Sassa, T., Sudo, Y., Matsushima, E., et al. (1997) · Nature · doi:10.1038/385634a0 · Cited by 710 · see citing works

D-Alanine Added to Antipsychotics for the Treatment of Schizophrenia

Tsai, G. E., Yang, P., Chang, Y., & Chong, M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.06.032 · Cited by 676 · see citing works

Effects of Ketamine in Normal and Schizophrenic Volunteers

Lahti, A. C. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00243-3 · Cited by 674 · see citing works

Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia

Meyer-Lindenberg, A., Miletich, R. S., Kohn, P. D., Esposito, G., Carson, R. E., Quarantelli, M., Weinberger, D. R., & Berman, K. F. (2002) · Nature Neuroscience · doi:10.1038/nn804 · Cited by 652 · see citing works

D-serine added to antipsychotics for the treatment of schizophrenia

Tsai, G. E., Yang, P., Chung, L.-C., LANGE, N. D., & Coyle, J. T. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00279-0 · Cited by 572 · see citing works

Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats

PYCOCK, C., Kerwin, R. W., & Carter, C. J. (1980) · Nature · doi:10.1038/286074a0 · Cited by 550 · see citing works

Provocative tests with psychostimulant drugs in schizophrenia

Lieberman, J. A., Kane, J. M., & Alvir, J. (1987) · Psychopharmacology · doi:10.1007/bf00216006 · Cited by 535 · see citing works

Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons

Seamans, J. K., Gorelova, N., Durstewitz, D., & Yang, C. R. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-10-03628.2001 · Cited by 507 · see citing works

D1Receptor Activation Enhances Evoked Discharge in Neostriatal Medium Spiny Neurons by Modulating an L-Type Ca2+Conductance

Hernández‐López, S., Bargas, J., Surmeier, D. J., Reyes, A., & Galarraga, E. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-09-03334.1997 · Cited by 495 · see citing works

5‐HT2A and D2 receptor blockade increases cortical DA release via 5‐HT1A receptor activation: a possible mechanism of atypical antipsychotic‐induced cortical dopamine release

Ichikawa, J., Ishii, H., Bonaccorso, S., Fowler, W. L., O'Laughlin, I. A., & Meltzer, H. Y. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00154.x · Cited by 495 · see citing works

Localization of dopamine D4 receptors in GABAergic neurons of the primate brain

Mrzljak, L., Bergson, C., Pappy, M., Huff, R., Levenson, R., & Goldman-Rakic, P. S. (1996) · Nature · doi:10.1038/381245a0 · Cited by 494 · see citing works

DARPP-32: Regulator of the Efficacy of Dopaminergic Neurotransmission

Fienberg, A. A., Hiroi, N., Mermelstein, P. G., Song, W., Snyder, G. L., Nishi, A., Chéramy, A., O'Callaghan, J. P., Miller, D. B., Cole, D. G., et al. (1998) · Science · doi:10.1126/science.281.5378.838 · Cited by 491 · see citing works

Efficacy of High-Dose Glycine in the Treatment of Enduring Negative Symptoms of Schizophrenia

Heresco‐Levy, U., Javitt, D. C., Ermilov, M., Mordel, C., Silipo, G. S., & Lichtenstein, M. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.1.29 · Cited by 487 · see citing works

Molecular Diversity and Functions of Glutamate Receptors

Nakanishi, S., & Masu, M. (1994) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.bb.23.060194.001535 · Cited by 447 · see citing works

A Placebo-Controlled Trial of D-Cycloserine Added to Conventional Neuroleptics in Patients With Schizophrenia

GOFF, D. C., Tsai, G. E., Levitt, J. J., AMICO, E. T., Manoach, D. S., Schoenfeld, D., Hayden, D. L., McCarley, R. W., & Coyle, J. T. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.1.21 · Cited by 436 · see citing works

Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia.

Kegeles, L., Abi-Dargham, A., Zea-Ponce, Y., Rodenhiser-Hill, J., Mann, J., Heertum, R. V. V., Cooper, T. B., Carlsson, A., & Laruelle, M. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00976-8 · Cited by 425 · see citing works

Glutamate receptor expression in schizophrenic brain

Meador‐Woodruff, J. H. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00044-2 · Cited by 412 · see citing works

The Mechanism of Action of Novel Antipsychotic Drugs

Meltzer, H. Y. (1991) · Schizophrenia Bulletin · doi:10.1093/schbul/17.2.263 · Cited by 412 · see citing works

Alterations of Benzodiazepine Receptors in Type II Alcoholic Subjects Measured With SPECT and [123I]Iomazenil

Abi‐Dargham, A., Krystal, J. H., Anjilvel, S., Scanley, B. E., Zoghbi, S. S., Baldwin, R. M., Rajeevan, N., Ellis, S. P., Petrakis, I. L., Seibyl, J. P., et al. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.11.1550 · Cited by 405 · see citing works

Dopamine D1/D5 receptor modulation of excitatory synaptic inputs to layer V prefrontal cortex neurons

Seamans, J. K., Durstewitz, D., Christie, B. R., Stevens, C. F., & B, T. J. S. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.301 · Cited by 399 · see citing works

Selective activation of dopamine transmission in the shell of the nucleus accumbens by stress

Kalivas, P. W., & Duffy, P. (1995) · Brain Research · doi:10.1016/0006-8993(95)00013-g · Cited by 395 · see citing works

Lamina-Specific Alterations in the Dopamine Innervation of the Prefrontal Cortex in Schizophrenic Subjects

Akil, M., Pierri, J. N., Whitehead, R. E., Edgar, C. L., Mohila, C., Sampson, A. R., & Lewis, D. A. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.10.1580 · Cited by 393 · see citing works

D1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: predominant and extrasynaptic localization in dendritic spines.

Smiley, J. F., Levey, A. I., Ciliax, B. J., & Goldman‐Rakic, P. S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5720 · Cited by 383 · see citing works

Dopaminergic modulation of impaired cognitive activation in the anterior cingulate cortex in schizophrenia

Dolan, R. J., Fletcher, P. C., Frith, C., Friston, K. J., Frackowiak, R. S. J., & Grasby, P. M. (1995) · Nature · doi:10.1038/378180a0 · Cited by 375 · see citing works

Dopamine D1 Receptor-Dependent Trafficking of Striatal NMDA Glutamate Receptors to the Postsynaptic Membrane

Dunah, A. W., & Standaert, D. G. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05546.2001 · Cited by 374 · see citing works

Dopaminergic control of synaptic plasticity in the dorsal striatum

Centonze, D., Picconi, B., Gubellini, P., Bernardi, G., & Calabresi, P. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01485.x · Cited by 361 · see citing works

Amelioration of negative symptoms in schizophrenia by glycine

Javitt, D. C., Zylberman, I., Zukin, S. R., Heresco‐Levy, U., & Lindenmayer, J. (1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.8.1234 · Cited by 353 · see citing works

Dopamine and N-Methyl-D- Aspartate Receptor Interactions in the Neostriatum

Cepeda, C., & Levine, M. S. (1998) · Developmental Neuroscience · doi:10.1159/000017294 · Cited by 350 · see citing works

The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies.

Laruelle, M. (2000) · Brain research. Brain research reviews · doi:10.1016/s0165-0173(99)00054-5 · Cited by 347 · see citing works

Elevated dopa decarboxylase activity in living brain of patients with psychosis

Reith, J., Benkelfat, C., Sherwin, A., Yasuhara, Y., Kuwabara, H., Andermann, F., Bachneff, S., Cumming, P., Diksic, M., & Dyve, S. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11651 · Cited by 342 · see citing works

Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment

Konradi, C., & Heckers, S. (2003) · Pharmacology &amp; Therapeutics · doi:10.1016/s0163-7258(02)00328-5 · Cited by 336 · see citing works

Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(beta-11C) DOPA and PET.

Lindström, L., Gefvert, O., Hagberg, G., Lundberg, T., Bergström, M., Hartvig, P., & Långström, B. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00109-2 · Cited by 332 · see citing works

Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients

Hietala, J. A., Syvälahti, E. K. G., Kuoppamäki, M., Hietala, J., Syvälahti, E. K. G., Haaparanta‐Solin, M., Kuoppamäki, M., Ruotsalainen, U., Vuorio, K. A., Räkköläinen, V., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91801-9 · Cited by 321 · see citing works

Dopamine, the prefrontal cortex and schizophrenia

Knable, M. B., & Weinberger, D. R. (1997) · Journal of Psychopharmacology · doi:10.1177/026988119701100205 · Cited by 304 · see citing works

Mechanisms of Dopamine Activation of Fast-Spiking Interneurons That Exert Inhibition in Rat Prefrontal Cortex

Gorelova, N., Seamans, J. K., & Yang, C. R. (2002) · Journal of Neurophysiology · doi:10.1152/jn.00335.2002 · Cited by 302 · see citing works

Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress

Deutch, A. Y., Clark, W. A., & Roth, R. H. (1990) · Brain Research · doi:10.1016/0006-8993(90)91557-w · Cited by 302 · see citing works

Neurotransmitter interactions in schizophrenia–therapeutic implications

Carlsson, A., Waters, N., & Carlsson, M. L. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00117-1 · Cited by 298 · see citing works

Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs

Grace, A. A., Bunney, B. S., Moore, H. M., & Todd, C. L. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10064-3 · Cited by 284 · see citing works

The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia

Daniel, D., Weinberger, D. R., Jones, D. W., Zigun, J. R., Coppola, R., Handel, S. F., Bigelow, L. B., Goldberg, T., Berman, K. F., & Kleinman, J. E. (1991) · Journal of Neuroscience · doi:10.1523/jneurosci.11-07-01907.1991 · Cited by 277 · see citing works

Dopamine Enhancement of NMDA Currents in Dissociated Medium-Sized Striatal Neurons: Role of D1 Receptors and DARPP-32

Flores‐Hernández, J., Cepeda, C., Hernández, E., Calvert, C. R., Jokel, E. S., Fienberg, A. A., Greengard, P., & Levine, M. S. (2002) · Journal of Neurophysiology · doi:10.1152/jn.00361.2002 · Cited by 270 · see citing works

Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates

Laruelle, M. A., Iyer, R. N., Al‐Tikriti, M. S., Zea‐Ponce, Y., Malison, R. T., Zoghbi, S. S., Baldwin, R. M., Kung, H. F., Charney, D. S., Hoffer, P. B., et al. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199701)25:1 · Cited by 264 · see citing works

Opposite Influences of Endogenous Dopamine D1and D2Receptor Activation on Activity States and Electrophysiological Properties of Striatal Neurons: Studies CombiningIn VivoIntracellular Recordings and Reverse Microdialysis

West, A. R., & Grace, A. A. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-01-00294.2002 · Cited by 252 · see citing works

Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia

Hietala, J. A., Syvälahti, E. K. G., Vilkman, H., Vuorio, K. A., Räkköläinen, V., Bergman, J. R., Haaparanta‐Solin, M., Solin, O. H., Kuoppamäki, M., Eronen, E., et al. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00113-3 · Cited by 243 · see citing works

Effects of NMDA antagonism on striatal dopamine release in healthy subjects: Application of a novel PET approach

Breier, A., Adler, C. M., Weisenfeld, N., Su, T.-P., Elman, I., Picken, L., Malhotra, A. K., & Pickar, D. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199806)29:2 · Cited by 226 · see citing works

LY354740 is a Potent and Highly Selective Group II Metabotropic Glutamate Receptor Agonist in Cells Expressing Human Glutamate Receptors

Schoepp, D. D., Johnson, B. G., Wright, R. A., Salhoff, C. R., Mayne, N. G., Wu, S., Cockerham, S. L., Burnett, J. P., BELEGAJE, R., Bleakman, D., et al. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(96)00160-8 · Cited by 225 · see citing works

Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans

Vollenweider, F. X., Vontobel, P., Øye, I., Hell, D., & Leenders, K. L. (2000) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00031-x · Cited by 223 · see citing works

Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson' disease

Starr, M. S. (1995) · Synapse · doi:10.1002/syn.890190405 · Cited by 214 · see citing works

Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations

Yamamoto, B., & Cooperman, M. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-07-04159.1994 · Cited by 203 · see citing works

Facilitated Glutamatergic Transmission in the Striatum of D2Dopamine Receptor-Deficient Mice

Cepeda, C., Hurst, R. S., Altemus, K. L., Flores‐Hernández, J., Calvert, C. R., Jokel, E. S., Grandy, D. K., Low, M. J., Rubinstein, M., Ariano, M. A., et al. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.85.2.659 · Cited by 203 · see citing works

Clozapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation

Rollema, H., Lu, Y., Schmidt, A. W., & Zorn, S. H. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)81951-6 · Cited by 203 · see citing works

Glutamate Modulation of Dopamine Measured in Vivo with Positron Emission Tomography (PET) and 11C-Raclopride in Normal Human Subjects

G Smith, P. D. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00092-4 · Cited by 201 · see citing works

Neuromodulatory actions of dopamine on synaptically-evoked neostriatal responses in slices

Levine, M. S., Li, Z., Cepeda, C., Cromwell, H. C., & Altemus, K. L. (1996) · Synapse · doi:10.1002/(sici)1098-2396(199609)24:1 · Cited by 200 · see citing works

Adjunctive high-dose glycine in the treatment of schizophrenia

Javitt, D. C., Silipo, G. S., Cienfuegos, A., Shelley, A. M., Bark, N. M., Park, M., Lindenmayer, J., Suckow, R. F., & Zukin, S. R. (2001) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145701002590 · Cited by 199 · see citing works

Postsynaptic integration of glutamatergic and dopaminergic signals in the striatum

Kötter, R. (1994) · Progress in Neurobiology · doi:10.1016/0301-0082(94)90037-x · Cited by 186 · see citing works

Developing a Neuronal Model for the Pathophysiology of Schizophrenia Based on the Nature of Electrophysiological Actions of Dopamine in the Prefrontal Cortex

Yang, C. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00112-2 · Cited by 184 · see citing works

Preparation of 11C-labelled SCH 23390 for the in vivo study of dopamine D-1 receptors using positron emission tomography

Halldin, C., Stone‐Elander, S., Farde, L., et al. (1986) · International Journal of Radiation Applications and Instrumentation Part A Applied Radiation and Isotopes · doi:10.1016/0883-2889(86)90044-4 · Cited by 175 · see citing works

PET Study of D1 Dopamine Receptor Binding in Neuroleptic-Naive Patients With Schizophrenia

Karlsson, P., Farde, L., Halldin, C., & Sedvall, G. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.5.761 · Cited by 172 · see citing works

The Synaptic Hypothesis of Schizophrenia

Frankle, W. G., Lerma, J., & Laruelle, M. A. (2003) · Neuron · doi:10.1016/s0896-6273(03)00423-9 · Cited by 167 · see citing works

Placebo-Controlled Trial of d -Cycloserine Added to Conventional Neuroleptics, Olanzapine, or Risperidone in Schizophrenia

Heresco‐Levy, U., Ermilov, M., Shimoni, J., Shapira, B., Silipo, G. S., & Javitt, D. C. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.3.480 · Cited by 167 · see citing works

d-Amphetamine-induced depression of central dopamine neurons: Evidence for mediation by both autoreceptors and a striato-nigral feedback pathway

Bunney, B. S., & Aghajanian, G. K. (1978) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00507966 · Cited by 165 · see citing works

D1 dopamine receptor binding in mood disorders measured by positron emission tomography

Suhara, T., Nakayama, K., Inoue, O., Fukuda, H., Shimizu, M., Mori, A., & Tateno, Y. (1992) · Psychopharmacology · doi:10.1007/bf02253582 · Cited by 163 · see citing works

In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats

Battaglia, G., Monn, J. A., & Schoepp, D. D. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00442-4 · Cited by 163 · see citing works

Presynaptic dopaminergic function in the striatum of schizophrenic patients

Dao-Castellana, M. H., Martinot, M. P., Hantraye, P., Attar-Levy, D., Rémy, P., Crouzel, C., Eric Artiges, A., Féline, A., Syrota, A., & Martinot, J. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(96)00102-8 · Cited by 160 · see citing works

New perspectives for the development of selective metabotropic glutamate receptor ligands

Pin, J., Colle, C. D., Bessis, A., & Acher, F. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00258-7 · Cited by 158 · see citing works

Endogenous dopamine release after pharmacological challenges in Parkinson's disease

Piccini, P., Pavese, N., & Brooks, D. (2003) · Annals of Neurology · doi:10.1002/ana.10526 · Cited by 157 · see citing works

Intracellular Modulation of NMDA Receptor Function by Antipsychotic Drugs

Leveque, J., Macias‐Konstantopoulos, W., Rajadhyaksha, A. M., Carlson, R. R., Barczak, A. K., Kang, S., Li, X., Coyle, J. T., Huganir, R. L., Heckers, S., et al. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04011.2000 · Cited by 148 · see citing works

Lack of apparent antipsychotic effect of the D1-dopamine recepotr antagonist SCH39166 in acutely ill schizophrenic patients

Karlsson, P., Farde, L., Härnryd, C., Sedvall, G., Smith, L. A., & Wiesel, F. ‐. (1995) · Psychopharmacology · doi:10.1007/bf02246068 · Cited by 148 · see citing works

Measurement of Striatal and Extrastriatal Dopamine D 1 Receptor Binding Potential With [ 11 C]NNC 112 in Humans: Validation and Reproducibility

Abi‐Dargham, A., Martínez, D., Mawlawi, O. R., Simpson, N. R., Hwang, D., Slifstein, M., Anjilvel, S., Pidcock, J., Guo, N., Lombardo, I., et al. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200002000-00003 · Cited by 147 · see citing works

Effects of MK-801 on spontaneous and amphetamine-stimulated dopamine release in striatum measured with in vivo microdialysis in awake rats

Miller, D. W., & Abercrombie, E. D. (1996) · Brain Research Bulletin · doi:10.1016/0361-9230(95)02144-2 · Cited by 146 · see citing works

Dopaminergic regulation of extracellular gamma-aminobutyric acid levels in the prefrontal cortex of the rat.

Grobin, A. C., & Deutch, A. Y. (1998) · PubMed · Cited by 141 · see citing works

Stimulation of prefrontal cortex at physiologically relevant frequencies inhibits dopamine release in the nucleus accumbens

Jackson, M. E., Frost, A. S., & Moghaddam, B. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00499.x · Cited by 139 · see citing works

Neuromodulatory actions of dopamine on synaptically-evoked neostriatal responses in slices

Levine, M. S., Li, S., Cepeda, C., Cromwell, H. C., & Altemus, K. L. (1996) · Synapse · doi:10.1002/syn.890240102 · Cited by 139 · see citing works

Dopamine-mediated regulation of striatal neuronal and network interactions

Onn, S., West, A. R., & Grace, A. A. (2000) · Trends in Neurosciences · doi:10.1016/s1471-1931(00)00020-3 · Cited by 135 · see citing works

Dopamine D2 receptor availability and amphetamine-induced dopamine release in unipolar depression

Parsey, R. V., Oquendo, M. A., Zea-Ponce, Y., Rodenhiser, J., Kegeles, L. S., Pratap, M., Cooper, T. B., Van Heertum, R., Mann, J. J., & Laruelle, M. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01089-7 · Cited by 133 · see citing works

Antipsychotic drugs classified by their effects on the release of dopamine and noradrenaline in the prefrontal cortex and striatum

Westerink, B. H. C., Kawahara, Y., Boer, P. D., Geels, C., Vries, J. B. D., Wikström, H., Kalkeren, A. A. V., Vliet, B. J. V., Kruse, C. G., & Long, S. K. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00935-3 · Cited by 120 · see citing works

Carbon-11-NNC 112: a radioligand for PET examination of striatal and neocortical D1-dopamine receptors.

Halldin, C., Foged, C., Chou, Y.-H., et al. (1998) · PubMed · Cited by 119 · see citing works

Dissociation of Haloperidol, Clozapine, and Olanzapine Effects on Electrical Activity of Mesocortical Dopamine Neurons and Dopamine Release in the Prefrontal Cortex

Gessa, G. L. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00087-7 · Cited by 110 · see citing works

NMDA antagonist effects on striatal dopamine release: Positron emission tomography studies in humans

Kegeles, L., Martinez, D., Kochan, L., Hwang, D., Huang, Y., Mawlawi, O., Suckow, R., Heertum, R. V. V., & Laruelle, M. (2002) · Synapse · doi:10.1002/syn.10010 · Cited by 106 · see citing works

Target‐Specific Glutamatergic Regulation of Dopamine Neurons in the Ventral Tegmental Area

Takahata, R., & Moghaddam, B. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751775.x · Cited by 101 · see citing works

CNS stimulants as tools in the study of schizophrenia

Angrist, B., & van Kammen, D. P. (1984) · Trends in Neurosciences · doi:10.1016/s0166-2236(84)80062-4 · Cited by 100 · see citing works

Mesocortical Dopaminergic Function and Human Cognition

Weinberger, D. R., Berman, K. F., & Chase, T. N. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb42117.x · Cited by 100 · see citing works

The depolarization block hypothesis of neuroleptic action: implications for the etiology and treatment of schizophrenia

Grace, A. A. (1992) · Springer eBooks · doi:10.1007/978-3-7091-9211-5_6 · Cited by 98 · see citing works

Differential effects of the D1-DA receptor antagonist SCH39166 on positive and negative symptoms of schizophrenia

den Boer, J. A., van Megen, H. J. G. M., Slaap, B. R., Westenberg, H. G. M., Fleischhacker, W. W., Louwerens, J. W., Burrows, G. D., & Srivastava, O. N. (1995) · Psychopharmacology · doi:10.1007/bf02246069 · Cited by 95 · see citing works

NNC-112, NNC-687 and NNC-756, new selective and highly potent dopamine D1 receptor antagonists

Andersen, P. H., Grønvald, F. C., Hohlweg, R., et al. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90578-r · Cited by 91 · see citing works

Clozapine Preferentially Increases Dopamine Release in the Rhesus Monkey Prefrontal Cortex Compared with the Caudate Nucleus

Youngren, K. D. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00082-7 · Cited by 85 · see citing works

Double-blind, placebo-controlled, crossover trial of D-cycloserine adjuvant therapy for treatment-resistant schizophrenia

Heresco‐Levy, U., Javitt, D. C., Ermilov, M., Silipo, G. S., & Shimoni, J. (1998) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145798001242 · Cited by 85 · see citing works

N-Methyl-D-Aspartate Receptor-Coupled GlycineB Receptors in the Pathogenesis and Treatment of Schizophrenia: A Critical Review

Millan, M. J. (2002) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007024606258 · Cited by 84 · see citing works

Stability of [123I]IBZM SPECT measurement of amphetamine-induced striatal dopamine release in humans

Kegeles, L. S., Zea‐Ponce, Y., Abi‐Dargham, A., Rodenhiser, J., Wang, T., Weiss, R., Heertum, R. L. V., Mann, J. J., & Laruelle, M. (1999) · Synapse · doi:10.1002/(sici)1098-2396(19990315)31:4 · Cited by 80 · see citing works

Metabotropic glutamate receptor agonists inhibit endogenous glutamate release from rat striatal synaptosomes

East, S. J., Hill, M. P., & Brotchie, J. M. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00119-6 · Cited by 78 · see citing works

Glutamate pharmacology and the treatment of schizophrenia: current status and future directions

Tamminga, C. A., Holcomb, H. H., Gao, X., & Lahti, A. C. (1995) · International Clinical Psychopharmacology · doi:10.1097/00004850-199509000-00005 · Cited by 74 · see citing works

The Neuropathology of Schizophrenia

Powers, R. E. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199907000-00001 · Cited by 71 · see citing works

Ketamine does not decrease striatal dopamine D 2 receptor binding in man

Aalto, S., Hirvonen, J., Kajander, J., Scheinin, H., Någren, K., Vilkman, H., Gustafsson, L. L., Syvälahti, E. K. G., & Hietala, J. A. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1236-6 · Cited by 69 · see citing works

Interaction Between A1 Adenosine and Class II Metabotropic Glutamate Receptors in the Regulation of Purine and Glutamate Release from Rat Hippocampal Slices

Iorio, P. D., Battaglia, G., Ciccarelli, R., Ballerini, P., Giuliani, P., Poli, A., Nicoletti, F., & Caciagli, F. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67010302.x · Cited by 66 · see citing works

Dopamine D1 and D2 receptor antagonism differentially modulates stimulation of striatal neurotransmitter levels by acid

Morari, M., O'Connor, W. T., Ungerstedt, U., & Fuxé, K. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90611-4 · Cited by 65 · see citing works

NMDA antagonist effects on striatal dopamine release: Microdialysis studies in awake monkeys

Adams, B. W., Bradberry, C., & Moghaddam, B. (2002) · Synapse · doi:10.1002/syn.1114 · Cited by 65 · see citing works

Neuropsychological correlates of central monoamine function in chronic schizophrenia: relationship between CSF metabolites and cognitive function

Kahn, R. S., Harvey, P. D., Davidson, M., Keefe, R. S. E., APTER, S., Neale, J. M., Mohs, R. C., & Davis, K. L. (1994) · Schizophrenia Research · doi:10.1016/0920-9964(94)90015-9 · Cited by 65 · see citing works

Striatal dopamine–NMDA receptor interactions in the modulation of glutamate release in the substantia nigra pars reticulata in vivo: opposite role for D1 and D2 receptors

Marti, M., Mela, F., Bianchi, C., Beani, L., & Morari, M. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01169.x · Cited by 61 · see citing works

An open trial of the D1 antagonist SCH 39166 in six cases of acute psychotic states

de Beaurepaire, R., Labelle, A., Jones, B., Naber, D., & Barnes, T. R. E. (1995) · Psychopharmacology · doi:10.1007/bf02246070 · Cited by 60 · see citing works

Striatal dopamine receptors and transporters in monkeys with neonatal temporal limbic damage

Heinz, A., Saunders, R., Kolachana, B., Jones, D., Gorey, J. G., Bachevalier, J., & Weinberger, D. R. (1999) · Synapse · doi:10.1002/(sici)1098-2396(199905)32:2 · Cited by 60 · see citing works

NNC 01-0687, a selective dopamine D1 receptor antagonist, in the treatment of schizophrenia

Karle, J., Lublin, H., Gerlach, J., Clemmesen, L., Hansen, L., Andersen, M. Ø., Andersen, J., Fensbo, C., Sloth-Nielsen, M., & Skrumsager, B. K. (1995) · Psychopharmacology · doi:10.1007/bf02246071 · Cited by 52 · see citing works

Clozapine: Dopamine D1Receptor Agonism in the Prefrontal Cortex as the Code to Decipher a Rosetta Stone of Antipsychotic Drugs

Ahlénius, S. (1999) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1999.tb01482.x · Cited by 50 · see citing works

Endogenous dopamine potentiates the effects of glutamate on extracellular GABA in the prefrontal cortex of the freely moving rat

Arco, A. D., & Mora, F. (2000) · Brain Research Bulletin · doi:10.1016/s0361-9230(00)00353-1 · Cited by 45 · see citing works

Recent Advances in the Teaching of Physics

Crew, H. (1904) · Science · doi:10.1126/science.19.482.481 · Cited by 36 · see citing works

Metabotropic glutamate receptors

Schoepp, D. D. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00824-9 · Cited by 27 · see citing works

Biphasic modulation of evoked [3H]D‐aspartate release by D‐2 dopamine receptors in rat striatal slices

Peris, J., Dwoskin, L. P., & Zahniser, N. R. (1988) · Synapse · doi:10.1002/syn.890020413 · Cited by 24 · see citing works

Enhancement of N-methyl-D-aspartate (NMDA) immunoreactivity in residual dendritic spines in the caudate-putamen nucleus after chronic haloperidol administration

Rodr�guez, J. J., & Pickel, V. M. (1999) · Synapse · doi:10.1002/(sici)1098-2396(19990915)33:4 · Cited by 19 · see citing works

Is clozapine an (partial) agonist at both dopamine D 1 and D 2 receptors?

Jackson, D. M., Wikström, H., & Liao, Y. (1998) · Psychopharmacology · doi:10.1007/s002130050665 · Cited by 18 · see citing works

Partial agonistic action of clozapine at dopamine D 2 receptors in dopamine depleted animals

Ninan, I., & Kulkarni, S. (1998) · Psychopharmacology · doi:10.1007/s002130050515 · Cited by 16 · see citing works

Characterization of [125I]SCH 23982 binding in human brain: Comparison with [3H]SCH 23390

Laruelle, M. A., Sidhu, A., Casanova, M. F., et al. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90631-3 · Cited by 14 · see citing works

Enhanced amphetamine-induced striatal [11C]raclopride displacement by the group II metabotropic glutamate receptor agonist LY354740 in baboons

van Berckel, B. N. M., Waterhouse, R. N., Hwang, D., et al. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)80353-4 · Cited by 2 · see citing works

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020 · see citing works

Increased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia

Kegeles, L. S., Abi-Dargham, A., Frankle, W. G., Gil, R., Cooper, T. B., Slifstein, M., Hwang, D.-R., Huang, Y., Haber, S. N., & Laruelle, M. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.10 · Cited by 565 · see citing works

Substantia nigra/ventral tegmental reward prediction error disruption in psychosis

Murray, G. K., Corlett, P. R., Clark, L., Pessiglione, M., Blackwell, A. D., Honey, G., Jones, P. B., Bullmore, E. T., Robbins, T. W., & Fletcher, P. C. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002058 · Cited by 532 · see citing works

Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia

Meyer, U., Feldon, J., Schedlowski, M., & Yee, B. K. (2005) · Neuroscience &amp; Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.10.012 · Cited by 494 · see citing works

Disrupted prediction-error signal in psychosis: Evidence for an associative account of delusions

Corlett, P. R., Murray, G. K., Honey, G. D., Aitken, M. R. F., Shanks, D. R., Robbins, T. W., Bullmore, E. T., Dickinson, A., & Fletcher, P. C. (2007) · Brain · doi:10.1093/brain/awm173 · Cited by 460 · see citing works

Toward a neurobiology of delusions

Corlett, P. R., Taylor, J. R., Wang, X.-J., Fletcher, P. C., & Krystal, J. H. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.06.007 · Cited by 394 · see citing works

From drugs to deprivation: A Bayesian framework for understanding models of psychosis

Corlett, P. R., Frith, C. D., & Fletcher, P. C. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1561-0 · Cited by 367 · see citing works

Comparative and Interactive Human Psychopharmacologic Effects of Ketamine and Amphetamine: Implications for Glutamatergic and Dopaminergic Model Psychoses and Cognitive Function

Krystal, J. H., Perry, E. B., Gueorguieva, R., Belger, A., Madonick, S. H., Abi-Dargham, A., Cooper, T. B., MacDougall, L., Abi-Saab, W., & D’Souza, D. C. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.9.985 · Cited by 317 · see citing works

An integrative perspective on the role of dopamine in schizophrenia

Maia, T. V., & Frank, M. J. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.05.021 · Cited by 293 · see citing works

The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse?

Meyer, U., Yee, B. K., & Feldon, J. (2007) · The Neuroscientist · doi:10.1177/1073858406296401 · Cited by 303 · see citing works

L-dopa modulates functional connectivity in striatal cognitive and motor networks: A double-blind placebo-controlled study

Kelly, C., de Zubicaray, G., Di Martino, A., Copland, D. A., Reiss, P. T., Klein, D. F., Castellanos, F. X., Milham, M. P., & McMahon, K. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.0810-09.2009 · Cited by 292 · see citing works

Functional Dysconnectivity of Corticostriatal Circuitry as a Risk Phenotype for Psychosis

Fornito, A., Harrison, B. J., Goodby, E., Dean, A., Ooi, C., Nathan, P. J., Lennox, B. R., Jones, P. B., Suckling, J., & Bullmore, E. T. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1976 · Cited by 279 · see citing works

Dysfunctional and Compensatory Prefrontal Cortical Systems, Genes and the Pathogenesis of Schizophrenia

Tan, H.-Y., Callicott, J. H., & Weinberger, D. R. (2007) · Cerebral Cortex · doi:10.1093/cercor/bhm069 · Cited by 266 · see citing works

Linking microcircuit dysfunction to cognitive impairment: Effects of disinhibition associated with schizophrenia in a cortical working memory model

Murray, J. D., Anticevic, A., Gancsos, M., Ichinose, M., Corlett, P. R., Krystal, J. H., & Wang, X.-J. (2014) · Cerebral Cortex · doi:10.1093/cercor/bhs370 · Cited by 255 · see citing works

Dopamine hypothesis of schizophrenia: Making sense of it all

Toda, M., & Abi-Dargham, A. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0041-7 · Cited by 235 · see citing works

Glutamatergic model psychoses: prediction error, learning, and inference

Corlett, P. R., Honey, G. D., Krystal, J. H., & Fletcher, P. C. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.163 · Cited by 229 · see citing works

Reduced prefrontal-parietal effective connectivity and working memory deficits in schizophrenia

Deserno, L., Sterzer, P., Wüstenberg, T., Heinz, A., & Schlagenhauf, F. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.3405-11.2012 · Cited by 214 · see citing works

Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons.

Pistis, M., Perra, S., Pillolla, G., Melis, M., Muntoni, A. L., & Gessa, G. L. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.05.006 · Cited by 194 · see citing works

Translational perspectives for computational neuroimaging

Stephan, K. E., Iglesias, S., Heinzle, J., & Diaconescu, A. O. (2015) · Neuron · doi:10.1016/j.neuron.2015.07.008 · Cited by 169 · see citing works

Food intake and reward mechanisms in patients with schizophrenia: implications for metabolic disturbances and treatment with second-generation antipsychotic agents

Elman, I., Borsook, D., & Lukas, S. E. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301051 · Cited by 169 · see citing works

Prefrontal cortex-nucleus accumbens interaction: in vivo modulation by dopamine and glutamate in the prefrontal cortex

Del Arco, A., & Mora, F. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.04.011 · Cited by 163 · see citing works

Impaired performance of alpha7 nicotinic receptor knockout mice in the five-choice serial reaction time task

Hoyle, E., Genn, R. F., Fernandes, C., & Stolerman, I. P. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0549-2 · Cited by 161 · see citing works

Neural basis of psychosis-related behaviour in the infection model of schizophrenia

Meyer, U., & Feldon, J. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.12.022 · Cited by 158 · see citing works

Prediction error, ketamine and psychosis: An updated model

Corlett, P. R., Honey, G. D., & Fletcher, P. C. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116650087 · Cited by 142 · see citing works

Local glutamate receptor antagonism in the rat prefrontal cortex disrupts response inhibition in a visuospatial attentional task

Murphy, E. R., Dalley, J. W., & Robbins, T. W. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2068-3 · Cited by 145 · see citing works

DRD2 polymorphisms modulate reward and emotion processing, dopamine neurotransmission and openness to experience

Peciña, M., Mickey, B. J., Love, T., Wang, H., Langenecker, S. A., Hodgkinson, C., Shen, P.-H., Villafuerte, S., Hsu, D., Weisenbach, S. L., et al. (2013) · Cortex · doi:10.1016/j.cortex.2012.01.010 · Cited by 123 · see citing works

Does dopamine mediate the psychosis-inducing effects of cannabis? A review and integration of findings across disciplines

Kuepper, R., Morrison, P. D., van Os, J., Murray, R. M., Kenis, G., & Henquet, C. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.05.031 · Cited by 116 · see citing works

Abnormal Neurotransmitter Release Underlying Behavioral and Cognitive Disorders: Toward Concepts of Dynamic and Function-Specific Dysregulation

Sarter, M., Bruno, J. P., & Parikh, V. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301285 · Cited by 100 · see citing works

Abnormal reward prediction-error signalling in antipsychotic naive individuals with first-episode psychosis or clinical risk for psychosis

Ermakova, A. O., Knolle, F., Justicia, A., Bullmore, E. T., Jones, P. B., Robbins, T. W., Fletcher, P. C., & Murray, G. K. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0056-2 · Cited by 91 · see citing works

Smooth pursuit and visual occlusion: active inference and oculomotor control in schizophrenia

Adams, R. A., Perrinet, L. U., & Friston, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047502 · Cited by 91 · see citing works

Brain Connectivity Abnormalities Predating the Onset of Psychosis: Correlation With the Effect of Medication

Schmidt, A., Smieskova, R., Aston, J., Simon, A., Allen, P., Fusar-Poli, P., McGuire, P. K., Riecher-Rössler, A., Stephan, K. E., & Borgwardt, S. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.117 · Cited by 93 · see citing works

How do glial-neuronal interactions fit into current neurotransmitter hypotheses of schizophrenia?

Kondziella, D., Brenner, E., Eyjolfsson, E. M., & Sonnewald, U. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2006.09.006 · Cited by 83 · see citing works

The potential role of lamotrigine in schizophrenia

Large, C. H., Webster, E. L., & Goff, D. C. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0020-9 · Cited by 69 · see citing works

Prefrontal and striatal glutamate differently relate to striatal dopamine: Potential regulatory mechanisms of striatal presynaptic dopamine function?

Gleich, T., Deserno, L., Lorenz, R. C., Boehme, R., Pankow, A., Buchert, R., Kuhn, S., Heinz, A., Schlagenhauf, F., & Gallinat, J. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0329-15.2015 · Cited by 62 · see citing works

Knowing when to stop: aberrant precision and evidence accumulation in schizophrenia

Limongi, R., Bohaterewicz, B., Nowicka, M., Plewka, A., & Friston, K. J. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2017.12.018 · Cited by 38 · see citing works

A predictive coding account of psychotic symptoms in autism spectrum disorder

van Schalkwyk, G. I., Volkmar, F. R., & Corlett, P. R. (2017) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-017-3065-9 · Cited by 25 · see citing works

MicroRNAs in schizophrenia: implications for synaptic plasticity and dopamine–glutamate interaction at the postsynaptic density. New avenues for antipsychotic treatment under a theranostic perspective

de Bartolomeis, A., Iasevoli, F., Tomasetti, C., & Buonaguro, E. F. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-8962-8 · Cited by 21 · see citing works

Ethanol Similarly Induces Ascorbic Acid Release in the Prefrontal Cortex and Striatum of Freely Moving Mice

Hou, Y., Wu, C., Yang, J., et al. (2006) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.126.671 · Cited by 1 · see citing works

[Effects of hemantane on the main subtypes of dopamine receptors in the rat striatum ex vivo].

Da, A., Zimin, I. A., & Kovalev, G. I. (2008) · PubMed

BRAIN DOPAMINE RECEPTORS IN SCHIZOPHRENIA

Lee, T., & Seeman, P. M. (1982) · Elsevier eBooks · doi:10.1016/b978-0-08-027987-9.50027-5 · Cited by 13 · see citing works

NEW DOPAMINE RECEPTOR SUBTYPES VS NON-DOPAMINE RECEPTORS IN RELATION TO SCHIZOPHRENIA AND NOVEL ANTIPSYCHOTIC DRUG ACTION

John, L. W. (1999) · Nihon shinkei seishin yakurigaku zasshi

Dopamine receptor hetero-oligomerization in the pathogenesis of schizophrenia: qualitative as opposed to quantitative notions of dopaminergic receptors

Tsai, S., & Hong, C. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00436-x · Cited by 3 · see citing works